Davinder S. Theti

Targeting the α-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase

Elisa Henderson, Vassilios Bavetsias, Davinder S. Theti et al. · Bioorganic & Medicinal Chemistry · 2006 · 136 citations

Medicine, Medicinal Chemistry, Pharmacology +13

BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing Tumors

David D. Gibbs, Davinder S. Theti, Nadya Wood et al. · Cancer Research · 2005 · 102 citations · Full text

Medicine, Oncology, Pharmacology +13

The Role of α-Folate Receptor-Mediated Transport in the Antitumor Activity of Antifolate Drugs

Davinder S. Theti, Ann L. Jackman · Clinical Cancer Research · 2004 · 68 citations · Full text

Medicine, Oncology, Pharmacology +15

Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.

Davinder S. Theti, Vassilios Bavetsias, Lorraine Skelton et al. · PubMed · 2003 · 54 citations

Medicine, Oncology, Pharmacology +13

Pegfilgrastim for peripheral CD34+ mobilization in patients with solid tumours

F. Willis, Penella J. Woll, Davinder S. Theti et al. · Bone Marrow Transplantation · 2009 · 14 citations

Medicine, Immunology, Oncology +10